Methionine Adenosyltransferase (MAT)

Methionine adenosyltransferase (MAT) inhibitors block production of the main methyl donor in cells. MAT enzymes combine methionine and ATP to form S-adenosylmethionine (SAM), the substrate of DNA, RNA, histone and protein methyltransferases. MAT1A is expressed mainly in the liver, whereas MAT2A supplies SAM in most other tissues and in tumor cells. In 2016, cancer cells lacking methylthioadenosine phosphorylase (MTAP) were shown to depend on MAT2A and protein arginine methyltransferase 5 (PRMT5). PF-9366 binds an allosteric site of MAT2A, as reported in 2017. AG-270, IDE397 and FIDAS-5 are further inhibitors that target the MAT2A isoform. The category also contains 3-TYP, an inhibitor of sirtuin 3 (SIRT3).

Items 26-38 of 38

  • MAT2A-IN-21
    Cat. No.
    A57808

    MAT2A-IN-21

    MAT2A-IN-21 is a potent inhibitor of methionine adenosyltransferase 2A (MAT2A), exhibiting an IC50 of 49 nM. This compound selectively targets MTAP-deficient cancer cells, making it a valuable tool for research in cancer metabolism and therapeutic intervention in MAT2A-related pathways. Its specificity and efficacy offer significant potential for studies aimed at understanding the implications of MAT2A inhibition in oncology.

    Out of stock

    All 3 sizes
  • MAT2A-IN-19
    Cat. No.
    A57809

    MAT2A-IN-19

    MAT2A-IN-19 is a potent inhibitor of methionine adenosyltransferase 2A (MAT2A), exhibiting an IC50 of 32.93 nM. This compound can be utilized in research focused on cellular metabolism and SAM-dependent methylation processes. It is particularly relevant in studies investigating cancer metabolism and targeted therapies.

    Out of stock

    All 3 sizes
  • MAT2A-IN-13
    Cat. No.
    A57810

    MAT2A-IN-13

    MAT2A-IN-13 is a selective inhibitor of methionine adenosyltransferase 2A (MAT2A), demonstrating significant oral bioavailability. This compound exhibits robust in vivo efficacy in the HCT-116 MTAP-deleted xenograft model, making it suitable for investigating the therapeutic potential within MTAP-deleted tumors. Its pharmacokinetic profile supports its application in various cancer research studies targeting MAT2A pathways.

    Out of stock

    All 3 sizes
  • MAT2A-IN-24
    Cat. No.
    A57811

    MAT2A-IN-24

    MAT2A-IN-24 is a potent inhibitor of methionine adenosyltransferase 2a (MAT2a), demonstrating an IC50 of 20 nM for enzyme inhibition. It exhibits significant antiproliferative activity against HAP1MTAP–/– cells, with an IC50 of 10 nM. This compound is valuable for research focused on tumorigenesis related to MTAP deficiency and offers a promising avenue for therapeutic exploration in relevant cancer models.

    Out of stock

    All 3 sizes
  • MAT2A-IN-5
    Cat. No.
    A57812

    MAT2A-IN-5

    MAT2A-IN-5 is a potent inhibitor of methionine adenosyltransferase 2A (MAT2A), which is often overexpressed in various cancers such as gastric, colon, liver, and pancreatic tumors. This compound effectively reduces the proliferative activity of MTAP-deficient cancer cells, making it a valuable tool for investigating cancer biology. MAT2A-IN-5 is suitable for research applications focused on understanding tumor metabolism and evaluating potential therapeutic targets in cancer research.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • MAT2A-IN-12
    Cat. No.
    A57813

    MAT2A-IN-12

    MAT2A-IN-12 is a selective allosteric inhibitor of methionine adenosyltransferase 2A (MAT2A), demonstrating an IC50 of 5 nM. This compound exhibits significant biological activity by effectively inhibiting cell proliferation in MTAP-/- cell lines. MAT2A-IN-12 serves as a valuable tool in research applications focused on metabolic regulation and cancer biology.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • MAT2A-IN-10
    Cat. No.
    A57814

    MAT2A-IN-10

    MAT2A-IN-10 is a potent inhibitor of methionine adenosyltransferase 2A (MAT2A) with an IC50 of 26 nM. This compound demonstrates significant biological activity in modulating S-adenosylmethionine levels, making it a valuable tool for cancer research. Its ability to selectively inhibit MAT2A positions it as a promising candidate for studies focused on metabolic pathways involved in tumorigenesis.

    5 mg
    $1,125.00
    50 mg
    $2,280.00
    All 3 sizes
  • MAT2A-IN-4
    Cat. No.
    A57815

    MAT2A-IN-4

    MAT2A-IN-4 is a selective inhibitor of methionine adenosyltransferase 2A (MAT2A). It exhibits significant biological activity by disrupting SAM (S-adenosylmethionine) synthesis, which can contribute to impaired cancer cell growth and proliferation. This compound is primarily utilized in research studies focused on cancer biology and the metabolic pathways involved in tumorigenesis.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • MAT2A inhibitor 5
    Cat. No.
    A57816

    MAT2A inhibitor 5

    MAT2A Inhibitor 5 is a selective inhibitor of methionine adenosyltransferase 2A (MAT2A) demonstrating an IC50 of 11 nM. This compound exhibits oral bioavailability and effective blood-brain barrier permeability, making it suitable for in vivo applications. MAT2A Inhibitor 5 is intended for research on tumor growth inhibition and the role of MAT2A in various cancer models.

    5 mg
    $465.00
    10 mg
    $760.00
    All 5 sizes
  • MAT2A-IN-16
    Cat. No.
    A57817

    MAT2A-IN-16

    MAT2A-IN-16 is a selective inhibitor of methionine adenosyltransferase 2A (MAT2A), demonstrating significant inhibition of cell proliferation in MTAP-deficient HCT-116 cells with an IC50 of 20 nM. This compound serves as a valuable tool for investigating the role of MAT2A in cancer biology and may aid in the development of novel therapeutic strategies targeting MAT2A-related pathways.

    Out of stock

    All 3 sizes
  • MAT2A-IN-2
    Cat. No.
    A63904

    MAT2A-IN-2

    MAT2A-IN-2 is a selective inhibitor of the methionine adenosyltransferase 2A (MAT2A) enzyme. Elevated MAT2A expression is associated with various tumors, including gastric, colon, liver, and pancreatic cancers. This compound effectively reduces the proliferative activity of cancer cells lacking the MTAP gene, making it a valuable tool for investigating cancer mechanisms and therapeutic strategies in MAT2A-overexpressing malignancies.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • MAT2A-IN-1
    Cat. No.
    A63908

    MAT2A-IN-1

    MAT2A-IN-1 is a potent inhibitor of methionine adenosyltransferase 2A (MAT2A). It effectively reduces the proliferative activity of MTAP-deficient cancer cells, which often present with elevated MAT2A expression in various tumors, including gastric, colon, liver, and pancreatic cancers. This compound is valuable for cancer research, particularly in studies targeting tumor metabolism and therapeutic strategies in MAT2A-overexpressing malignancies.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • MAT2A-IN-3
    Cat. No.
    A63909

    MAT2A-IN-3

    MAT2A-IN-3 is a potent inhibitor of methionine adenosyltransferase 2A (MAT2A), which is overexpressed in various cancers, including gastric, colon, liver, and pancreatic tumors. This compound effectively reduces the proliferative activity of MTAP-deficient cancer cells, making it a valuable tool for investigating cancer biology and therapeutic strategies. MAT2A-IN-3 holds promise for advancing research into cancer treatments and understanding metabolic vulnerabilities in tumorigenesis.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes

Items 26-38 of 38

Added to your cart

View Cart Checkout

    Loading...